Research Funding Board

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• Due: Rolling
• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Alzheimer’s Association – Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN)

• Due: Rolling
• Funding: Not specified
• Project period:  Up to 3 to 12 months
• Purpose: To support early career researchers who have not yet had the opportunity to fully establish their labs and acquire ongoing funding, and to provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, Frontotemporal Dementia, Parkinson’s disease, Dementia with Lewy Bodies, atypical Parkinson’s and/or other related disorders that have been impacted by NIH changes.
• Eligibility: An applicant must be an Early Stage Investigator (ESI), defined as a Program Director/Principal Investigator who has completed their terminal research degree or post-graduate clinical training, whichever is later, within the past 10 years and has not previously competed successfully as a PD/PI for a substantial NIH independent research award (see NIH early career definition for more details). This grant is intended for ESI applicants who can demonstrate disruption in either their K or R or other ESI specific investigator-led award in recent months due to U.S. federal funding challenges and must provide the NIH review and/or summary. Applicants must be able to demonstrate financial need for their continued research program to move forward.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Rolling; submission deadlines for subsequent review ocurring on August 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-InitiatedStudies(IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Brutten Family Foundation – Grants

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
• Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.

Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant

• Due: Rolling submission
• Funding: Up to $10,000
• Project period:  Not specified
• Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
• Eligibility: Researcher should have necessary data in hand at time of application submission.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Diamond Blackfan Anemia Foundation – Research Grant

• Due: Rolling
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
• Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.

FamilieSCN2A Foundation – Hodgkin-Huxley Research Grant

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
• Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research

• Due: Rolling LOI submission
• Funding: Not specified
• Project period: Not specified
• Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
• Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Hearst Foundations – Funding Priorities in Health

• Due: Rolling
• Funding: $100,000 minimum
• Project period: Not specified
• Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
• Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants

• Due: Open
• Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
• Project period: Not specified
• Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
• Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.

Malan Syndrome Foundation – Research Grant Program

• Due: Rolling
• Funding: $30,000 per year
• Project period: 1 to 2 years
• Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
• Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.

Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program

• Due: Rolling pre-application
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
• Eligibility: Open to industry and industry-academia collaborations.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Pediatric Brain Tumor Foundation – Pediatric Brain Tumor Research Funding Proposals

• Due: Rolling
• Funding: Not specified
• Project Period: 1 to 3 years
• Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
• Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.

Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program

• Due: Rolling
• Funding: Not specified
• Project period: 2 years
• Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
• Eligibility: Applicants must be fellows or early-stage faculty.

Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals

• Due: Rolling
• Funding: $50,000
• Project period: Up to 2 years
• Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
• Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.

Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program

• Due: Rolling
• Funding: Not specified.
• Project period: 2 years
• Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
• Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

The Milbank Foundation – Grants

• Due: Open (LOIs required)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
• Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

W.K. Kellogg Foundation – Grants

• Due: Open (LOIs accepted at any time)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
• Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

March

ALS Finding a Cure^® – From Resilience to Vulnerability: Defining the Biological Determinants of ALS Onset RFP

• Due: March 30, 2026 (LOI)
• Funding: Up to $400,000
• Project Period: Up to 2 years
• Purpose: To support innovative and original proposals that are translational in nature, addressing motor neuron vulnerability, biological resilience, and early disease initiation.
• Eligibility: Investigators at academic, clinical, and research institutions worldwide.
• Eligibility: Investigators at academic, clinical, and research institutions worldwide. Applicants at all career stages are eligible. Cross-institutional and multidisciplinary teams may apply.

Foundation for Physical Therapy Research (FPTR) – 2026 Postdoctoral Fellowship

• Due: March 30, 2026
• Funding: $75,000
• Project Period: 1 year
• Purpose: To support early-career physical therapy researchers in expanding their knowledge, research skills and experience to help them advance and be successful as independent investigators.
• Eligibility: Applicants must have a doctoral degree (PhD, EdD, DSc, or equivalent) from an accredited institution after June 1, 2024, be employed by the institution where the fellowship will be completed, be a U.S. citizen or permanent resident of the U.S. with the right to work (Green Card) that is valid for the entire fellowship period and possess a physical therapy license granted by a U.S. state or U.S. territory. A mentor, 100% protected time, and APTA membership are required. Membership must be maintained for at least one year after the fellowship period. is required. Applicants must demonstrate commitment to further the physical therapy profession through research and teaching in the U.S. or its territories.

Alzheimer’s Drug Discovery Foundation & Association for Frontotemporal Degeneration (AFTD) – The Treat FTD Fund

• Due: March 31, 2026 (LOI)
• Funding: Up to $2.5M
• Project Period: Up to 3 years
• Purpose: To support clinical trial readiness activities or early/mid-stage clinical trials with clear go/no-criteria for later stage drug development (helping to build a better understanding of FTD pathophysiology, biological mechanisms of disease, and analytically and clinically validated biomarkers with a well-defined context-of-use).
• Eligibility: Academic medical centers, universities, or non-profits, biotechnology companies (existing companies and new startups) are all eligible. Industry partnerships are encouraged.

American Association for Respiratory Care (AARC) – 2026 AARC Vision Grant

• Due: March 31, 2026 (LOI)
• Funding: $50,000
• Project Period: 1 year
• Purpose: To support proposals that advance the recognition, value, and role of respiratory therapists within healthcare teams or that demonstrate the cost-effectiveness of respiratory care through lower morbidity and/or mortality, improved quality, and enhanced patient safety. An emphasis on education that increases competency is encouraged.
• Eligibility: Preference will be given to proposals where the respiratory therapists will be the PI or co-PI. At least one member of the research group must be an active member of the AARC.

Incyte – Ingenuity Awards – Hidradenitis Suppurativa™ (HS)

• Due: March 31, 2026 (LOI)
• Funding: Not specified
• Project Period: 1 year
• Purpose: To support innovative initiatives that address specific needs for people impacted within the HS community?
• Eligibility: Invited applicants will be asked to complete a round two application form. U.S.-based non-profit 501(c)(3), patient, policy and caregiver organizations, Healthcare providers, junior faculty from healthcare organizations, individuals or other companies collaborating with these organizations and institutions may apply.

Pfizer – Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)

• Due: March 31, 2026
• Funding: Up to $250,000
• Project Period:18 months
• Purpose: To support sustainable projects that improve biomarker testing practices, strengthen targeted therapy selection, and support care teams in implementing patient-centered protocols with the goal of improving treatment decision-making for patients with mCRC.
• Eligibility: Eligible applicants include various patient care organizations actively engaged in mCRC management, that are affiliated with a laboratory capable of performing biomarkers testing for mCRC or have established processes to refer such testing to one or more qualified reference laboratories. Two PIs must be selected to lead the project (one pathologist and one oncologist). The Pathologist PI/co-PI must be an active member of ASCP at the time of award.

April

American Association of Obstetrics and Gynecologists Foundation – Bridge Funding Award: RFP

• Due: April 1, 2026
  Funding: $25,000
• Project Period: 1 year
• Purpose: A joint effort (ABOG/AAOGF, American College of Obstetricians and Gynecologists (ACOG), and the Jones Foundation for Reproductive Medicine) to support physician scientists in obstetrics and gynecology who have submitted proposals but have not been successful in obtaining R01 or equivalent independent research funding or who have a temporary lapse in funding (R01 or equivalent grant not renewed).
• Eligibility: Candidates with MD or DO degrees at the rank of assistant professor or above of Obstetrics and Gynecology, who have successfully completed a mentored research award or have previously had an R grant and who have applied for funding but who have not been successful in either obtaining or maintaining independent research funding may apply.

American Association of Obstetrics and Gynecologists Foundation (AAOGF) & Society of Academic Specialists in General Obstetrics and Gynecology (SASGOG) – AAOGF/SASGOG Pilot Grant

• Due: April 1, 2026
  Funding: $25,000
• Project Period: 1 year
• Purpose: A joint effort (between AAOGF and SASGOG) to aid a qualified candidate in generating preliminary data and fostering a mentor relationship in anticipation of applying for a future mentored award (such as the AAOGF Physician Scientist Award, a NIH K08, a NIH Reproductive Scientist Award, and others).
• Eligibility: Applicants must have an MD or DO and be ABOG certified/eligible at the time of the award. Eligible candidates must have completed an ACGME approved residency program in obstetrics and gynecology, hold an academic appointment of assistant or associate professor, and have completed the PROGRESS Course (Program for Researchers in Obstetrics, Gynecology, and Reproductive Sciences) or have completed a research fellowship in general obstetrics and gynecology. Applicants must be supported by their sponsoring academic department.

Pfizer – 2026 Inflammatory Bowel Disease (IBD) Fellowship – U.S. (RFP)

• Due: April 1, 2026
• Funding: Up to $80,000
• Project Period: 1 year
• Purpose: To support fellowship programs at institutions with clinical training programs in regions where there are continued workforce challenges and that have a strong focus on healthcare equity, clinical practice, research, education, and advancing the standard of care in IBD (i.e., IUS, AI endoscopy, machine learning) to further the understanding of IBD.
• Eligibility: US-based accredited academic institutions may apply. Fellows supported by this grant must be a U.S. citizen, permanent resident, refugee, or asylee, or hold an appropriate non-immigrant visa status authorizing employment in the U.S., and they must have an MD or equivalent degree and be recent graduates from an accredited internal medicine residency program or current fellows in their second or third year of GI training or recent graduates committed to developing a specialized expertise in IBD with a goal of continuing onto a career devoted to the care of patients with IBD.

American Psychological Foundation (APF) – Visionary Grants

• Due: April 3, 2026
• Funding: $20,000
• Project Period: Not specified
• Purpose: Provides seed money to support innovation in research, education and intervention projects and programs that use psychology to solve social problems in various  priority areas including but not limited to applying psychology to at-risk, vulnerable populations, preventing violence, understanding the connection between behavior and health. Priority will be given to projects that have potential to attract further support from major federal or foundation funding agencies.
• Eligibility: Graduate students or early career researchers (no more that 10 years postdoctoral) affiliated with an educational or scientific institution, a nonprofit charitable, organization, or a governmental entity operating exclusively for charitable and educational purposes, who have demonstrated competence and capacity to complete the proposed work may apply.

Pfizer – 2026 Headache Medicine Fellowship – US

• Due: April 6, 2026
• Funding: $90,000
• Project Period: 1 year
• Purpose: To support headache medicine fellowship programs at institutions with clinical training programs that demonstrate a strong commitment to clinical practice, research, and education to advance the understanding of headache medicine.
• Eligibility: U.S.-based accredited academic institutions may apply. Any fellow that will be supported by this grant must be a U.S. citizen, permanent resident, refugee, or asylee, or hold an appropriate non-immigrant visa status authorizing employment in the U.S. The fellow should be a physician (MD or DO) who is eligible to and plan to obtain a UCNS (United Council for Neurologic Subspecialties) certification upon completion of the fellowship, or be an MD or DO with a specialty outside of neurology (Primary Care, Emergency Medicine, OB/GYN, etc.).

American Association for Cancer Research – AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Fellowship

• Due: April 9, 2026
• Funding: $130,000
• Project Period: 2 years
• Purpose: A joint effort to support and encourage innovative research projects with direct applicability and relevance to ILC and to help establish a successful career path in the field for postdoctoral or clinical research fellows working on mentored ILC research projects.
• Eligibility: Applicants must have a PhD, MD, MD/PhD, or equivalent in a related field, a mentored research position as a postdoctoral fellow, clinical research fellow, or equivalent, and must have completed their terminal doctoral degree within the past five years. MD applicants must have completed their most recent doctoral degree or medical residency within the past five years. AACR membership is required.

American Association for Cancer Research – AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Innovation and Discovery Grants

• Due: April 9, 2026
• Funding: $50,000
• Project Period: 1 year
• Purpose: A joint effort to support innovative research projects focused on invasive lobular carcinoma (ILC). Proposals focused on any aspect of basic or clinical research directly related to lobular breast cancer are eligible. Rare ILC subtypes-such as pleomorphic and Priority consideration will be given to proposals investigating rare ILC subtypes such as pleomorphic and alveolar ILC, and studies on dormancy and recurrence.
• Eligibility: Applicants must have a PhD, MD, MD/PhD, or equivalent in a related field. At the start of the grant term (July 1, 2026) applicants must be independent PIs affiliated with an academic medial, or non-profit research institution. AACR membership is required. Applicants applying from an institution located in a country in which they are not a citizen or permanent resident must ensure their visa status remains valid for the entire duration of the project. AACR membership is required.

National Brain Tumor Society – Quality of Life (QoL) Research Award

• Due: April 13, 2026 (LOI)
• Funding: Up to $200,000
• Project Period: 2 years
• Purpose: To support research proposals (including clinical research and trials in the focus areas of survivorship and behavioral and emotional healthcare/support) aimed at improving the health and wellbeing of adults, young adults, or children diagnosed with primary brain and CNS malignant tumors.
• Eligibility: PIs and co-PIs must be affiliated with a U.S.-based academic institution, health care organization, or community-based organization with demonstrated infrastructure  and experience in clinical research, including access to appropriate human subjects’ research oversight, and must hold an MD, PhD, MD/PhD, or equivalent. PIs must be independent investigators with a demonstrated track record or peer-reviewed publications and prior funding to support successful completion of the proposed project within the funding period.

Alex’s Lemonade Stand Foundation for Childhood Cancer – 2026 Reach Grant

• Due: April 14, 2026
• Funding: Up to $250,000
• Project Period: 2 years
• Purpose: To support translational, pre-clinical hypothesis-driven research projects that are necessary to move a study from pre-clinical trial status to a phase I and/or II clinical trial, two to three years from the project’s end date.
• Eligibility: Applicants must be faculty (or equivalent) at an academic institution, hold an MD, PhD, MD/PhD or equivalent degree, and have a demonstrated track record of pediatric cancer research with experience in translational research. Faculty members not at the Assistant Professor rank yet must have a senior collaborator on the project with a letter of commitment demonstrating their role and support for the applicant.

American Association for Cancer Research – AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga

• Due: April 14, 2026 (LOI)
• Funding: Up to $300,000
• Project Period: 3 years
• Purpose: To support early career physician-scientists conducting translational-, clinical-, or population sciences-focused oncology research that could lead to the development of innovative targeted therapeutics.
• Eligibility: At the start of the grant term (November 1, 2026) applicants must hold an MD, MD/PhD, DO or equivalent in a related field, and must have started their first independent faculty position (assistant professor, instructor, research assistant professor, or equivalent) within the past 6 years from the start of the grant term. 50% protected time and AACR membership required.

American Federation for Aging Research – McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss

• Due: April 15, 2026
• Funding: $750,000
• Project Period: Up to 3 years
• Purpose: A joint award between the McKnight Brain Research Foundation (MBRF) and the American Federation for Aging Research (AFAR) to support high risk/high reward, innovative and transformative studies focusing on clinical translational research or basic biological mechanisms underlying cognitive aging and age-related memory loss.
• Eligibility: Candidates must be independent investigators who have completed research training prior to October 1, 2026 (PhD candidates no more than 7 years from the completion of formal post-doctoral research training post-PhD; MD or combined degree candidates no more than 12 years from residency completion). Candidates must also be tenure-track faculty or equivalent in an academic or non-profit institution and must provide evidence of long-term institutional support and have a proven track record of research accomplishments in cognitive aging, demonstrated by publications in high-impact journals, awards, and other metrics of peer recognition.

Pfizer – Applications of Artificial Intelligence to Improve Speed / Precision of Treatment Selection and Clinical Management for Patients with Invasive Mold Infections

• Due: April 15, 2026 (LOI)
• Funding: Up to $30,000
• Project Period: 1 year
• Purpose: To support U.S.-based education projects to increase the awareness of healthcare professionals (HCPs) on the opportunities and challenges of applying artificial intelligence, integrated diagnostic & antifungal stewardship and clinical decision support tools to improve speed and precision of treatment selection and to enhance clinical management for patients with invasive mold infections (IMIs).
• Eligibility: Medical, mycology/microbiology, allied health, and/or pharmacy professionalschools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible. Proposals may be submitted by U.S.-, Canada-, or Japan-based organizations if the projects are focused on education activities in Australia, China, France, Germany, Italy, Spain, South Korea, Taiwan and the U.K. or any country outside the U.S., Canada, or Japan. Projects with a geographical scope aligned with the countries above and other countries outside the USA, Canada or Japan will be considered. Requesting organizations must be legally able to receive award funding directly from Pfizer Inc.

Pfizer – Applications of Artificial Intelligence to Improve Speed / Precision of Treatment Selection and Clinical Management for Patients with Invasive Mold Infections

• Due: April 15, 2026 (LOI)
• Funding: Up to $30,000
• Project Period: 1 year
• Purpose: To support U.S.-based education projects to increase the awareness of healthcare professionals (HCPs) on the opportunities and challenges of applying artificial intelligence, integrated diagnostic & antifungal stewardship and clinical decision support tools to improve speed and precision of treatment selection and to enhance clinical management for patients with invasive mold infections (IMIs).
• Eligibility: Medical, mycology/microbiology, allied health, and/or pharmacy professionalschools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible. Proposals may be submitted by U.S.-, Canada-, or Japan-based organizations if the projects are focused on education activities in Australia, China, France, Germany, Italy, Spain, South Korea, Taiwan and the U.K. or any country outside the U.S., Canada, or Japan. Projects with a geographical scope aligned with the countries above and other countries outside the USA, Canada or Japan will be considered. Requesting organizations must be legally able to receive award funding directly from Pfizer Inc.

PhRMA Foundation – Faculty Starter Grants

• Due: April 15, 2026 (LOI)
• Funding: $100,000
• Project Period: 1 year
• Purpose: To support U.S.-based education projects to increase the awareness of healthcare professionals (HCPs) on the opportunities and challenges of applying artificial intelligence, integrated diagnostic & antifungal stewardship and clinical decision support tools to improve speed and precision of treatment selection and to enhance clinical management for patients with invasive mold infections (IMIs).
• Eligibility: Applicants must be full-time, promotion-eligible, research-intensive faculty (with faculty status that began after January 1, 2025 and a terminal degree conferred after January 1, 2017) at a PhD-granting accredited U.S. university by the time of LOI submission. Preference will be given to applicants with startup funding less than $750,000. Applicants with funding over $250,000 are ineligible. A minimum of three first author publications is required for eligibility.

  Drug Discovery Faculty Starter Grant – For individuals beginning independent careers in drug discovery research at the faculty level at an accredited U.S. university.
  Drug Delivery Faculty Starter Grant – For individuals beginning independent faculty careers at an accredited U.S. university in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

PhRMA Foundation – Postdoctoral Fellowships

• Due: April 15, 2026 (LOI)
• Funding: $100,000
• Project Period: 12, 18, or 24 months
• Purpose: To provide stipend support to promising postdoctoral trainees seeking to further develop and refine their research skills.
• Eligibility: Applicants must hold a PhD, PharmD, MD, or equivalent, be based at a PhD-granting accredited U.S. university, and be in a postdoctoral position at the time of the LOI submission. Applicants are not eligible if their terminal doctoral degree was granted before January 1, 2024 and if they have less than two first author publications. NIH K99/R00 or NIH-F awardees are not eligible. Recipients of NIH TL1, T32, T90, or T35 awards or a nonprofit/professional society equivalent) may apply if they are willing to forgo the institutional training slot if funded by a PhRMA Foundation award.
  Drug Discovery Postdoctoral Fellowships – To support novel, early-stage, drug discovery research with a clear potential for translation to humans.
  Drug Delivery Postdoctoral Fellowships – To support therapeutically relevant research that optimizes drug composition, dosage, and delivery to make treatments clinically viable, safer, more effective, and/or easier to manage for patients.

Whitehall Foundation – Grants-in-Aid

• Due: April 15, 2026 (LOI)
• Funding: Up to $30,000
• Project Period: 1 year
• Purpose: To support scholarly research in the life sciences (dynamic areas of basic biological research that are not heavily supported by federal funding or other foundations with specialized missions).
• Eligibility: Intended for researchers at the assistant professor level who experience difficulty in competing for research funds because they have not yet become firmly established. Grants-in-Aid can also be made to senior scientists.

American Psychological Foundation (APF) – Walter Katkovsky Research Grants

• Due: April 17, 2026
• Funding: $22,500
• Project Period: Not specified
• Purpose: To support research proposals focused on improving the understanding, based on theory or methods, of how psychotherapy promotes behavioral, emotional, or cognitive changes and should result in the collection of new data.
• Eligibility: Applicants must be psychologists no more than 12 years postdoctoral, be affiliated with a nonprofit charitable, educational, or scientific institution, or governmental entity operating exclusively for charitable and educational purposes, and must have demonstrated competence and capacity to complete the project proposed.

The American Society for Clinical Investigation (ASCI) – Call for Nominations Early Career Impact Awards

• Due: April 20, 2026 (nomination deadline)
• Funding: $100,000 per year
• Project Period: 3 years
• Purpose: To support research by physician-scientists who are early in their first full-time faculty appointment, who are conducting impactful research that seeks to enhance the understanding of disease mechanisms, accelerate translational discoveries, and drive the development of cutting-edge diagnostics and therapies. Genentech’s therapeutic areas of interest: Immunology, Infectious disease, Neuroscience, Oncology, and Ophthalmology.
• Eligibility: Applicants must hold an MD, MD/PhD, or equivalent degree, be within three years of their first full-time academic appointment at the Instructor or Assistant Professor or equivalent level (tenure- and non-tenure-track) at an accredited U.S.-based university/research institution at the Award start date. The applicant’s organization must commit to matching the award amount. 75% protected time is required.

American Society for Reproductive Medicine (ASRM) – ASRM Pilot Exploratory Research Grant

• Due: April 20, 2026
• Funding: Up to $50,000
• Project Period: 2 years
• Purpose: To support preliminary studies in new areas of research conducted by an investigator. Projects can involve physiological, psychological, biochemical, pharmacological, genetic, environmental, clinical, sociocultural, or pathological investigations (for new or ongoing research or clinical investigation projects).
• Eligibility: Independent investigators who are full-time clinician/physician scientists at an academic, private practice, other non-profit or for-profit organizations, who have an MD, MD/PhD, PhD, DO, ScD, or equivalent, and a track record in basic, clinical, or translational research in reproductive medicine may apply. Applicants must have completed their research and/or clinical training at least three years prior to submitting the application. Membership required by time of the award initiation and throughout the duration of the grant.

Kidney Cancer Association – 2026 Grant Awards

• Due: April 20, 2026
• Funding: $75,000 or $25,000
• Project Period: 1 year
• Purpose: To support promising young-to mid-career investigators to foster innovative kidney cancer research and yield preliminary data necessary for obtaining funding from larger institutions.
• Eligibility: Applicants must have a doctoral degree (MD, Ph.D., or equivalent). Postdoctoral researchers who have completed their first doctoral degree within the past seven years and who do not hold a faculty position should consider collaboration with a mentor who has a well-established career in the field.Trailblazer Awards – For any focus in kidney cancer ($75,000). This program allows use of funds for accessing biological samples through Pattern.org.
  Chromophobe RCC Focus Awards – In partnership with COA, for projects that investigate the distinct biological features and therapeutic vulnerabilities of chromophobe renal cell carcinoma, aimed at advancing mechanistic understanding and informing future treatment strategies ($25,000).
  Interdisciplinary Medicine Focus Awards – In partnership with the Michael and Ina Korek Foundation, for exploration of the relationship between kidney cancer and various lifestyle factors. Proposals should aim to identify modifiable risk factors and develop preventive strategies or interventions that can be rapidly applied in clinical settings to aid in treatment or outcomes ($75,000).

Pfizer – Pfizer External Research & Grants (ER&G): Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC) RFP

• Due: Apr 21, 2026
• Funding: Up to $250,000
• Project Period:Not specified
• Purpose: To support independent education projects aimed at improving knowledge and competence of combinations in the 1L HER2+ MBC maintenance setting, overall treatment paradigm and evolving first-line standard of care options for patients with HER2+ MBC, and safety profiles of available therapies.
• Eligibility: U.S.-based medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions; professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible to apply.

American Psychological Foundation (APF) – Direct Action Visionary Grants

• Due:April 30, 2026 (LOI)
• Funding: Up to $60,000
• Project Period: : Not specified
• Purpose: To fund innovative interventions, based on psychological knowledge, that directly address pressing needs of communities. Projects should support one of APF’s four Visionary Priorities.
• Eligibility: Applicants at any level who have demonstrated competence and capacity to execute the proposed work may apply. Projects must be an evidence-based psychological intervention or resource. An expert in the relevant evidence-based psychological intervention or resource used for the project must be centrally involved throughout the funding timeline.

May

Bristol Myers Squibb Foundation – Robert A. Winn Excellence in clinical Trials: Career Development Award (Winn CDA) 

• Due: May 4, 2026
• Funding: $120,000 per year
• Project Period: 2 years
• Purpose: To support the training of early career clinician scientists in designing and implementing clinical trials that engage more communities in research areas that include cancer, cardiovascular and cardio-metabolic disease, and neuropsychiatry.
• Eligibility: Applicants must be physician (MD, DO, or international equivalent), have an active U.S. medical license, and be in the first to eighth year of a full-time clinical faculty appointment. U.S. citizenship of Lawful Permanent Residence is required. Applicants must work under the guidance of an experienced mentor who is a clinical investigator.

Pfizer – Pfizer Independent Medical Education Grant RFP: Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) – Education for Healthcare Professionals

• Due: May 5, 2026
• Funding: $50,000
• Project Period: 1 year
• Purpose: To strengthen clinical trial readiness for Sickle Cell Disease (SCD) by enhancing workforce education and building durable internal infrastructure to support high-quality clinical research in SCD.
• Eligibility: Medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); patient advocacy groups, professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement may apply. The applicant must be the project/program lead or an authorized designee. The award will be given to the institution.

Pfizer – 2026-RD-US-CardiacAmyloidosis-Fellowship RFP

• Due: May 6, 2026
• Funding: Up to $80,000
• Project Period: 1 year
• Purpose: To support institutions with fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers that have a strong focus on clinical practice, research, and education to further the understanding of ATTR cardiac amyloidosis and to promote the importance of training healthcare professionals to recognize, diagnose and manage the disease and conduct research in this area.
• Eligibility: Accredited, U.S.-based academic institutions, (in particular, institutions with clinical training programs in regions where there are continued workforce challenges and that have a strong focus on clinical practice, research, and education to further the understanding of ATTR cardiac amyloidosis) are eligible. All fellows who will be supported by this grant at an awarded institution must be a U.S. citizen, permanent resident, refugee, or asylee, or hold an appropriate non-immigrant visa status authorizing employment in the U.S.

Pfizer – Advances in Migraine Management

• Due: May 8, 2026
• Funding: Up to $200,000
• Project Period: 2 years
• Purpose: To support projects that identify and address the educational needs of healthcare professionals to improve the care, management, and outcomes of adult patients with migraine.
• Eligibility: U.S.-based medical, dental, nursing, allied health, and/or pharmacy professional schools, healthcare institutions, professional organizations/medical societies, medical education companies, and other entities with a mission related to healthcare professional education and/or healthcare improvement may apply. The PI must be an employee or contractor of the organization submitting the application. For projects offering continuing education credit, the requesting organization must be accredited.

Alzheimer’s Drug Discovery Foundation & Association for Frontotemporal Degeneration (AFTD) – Request for Proposals: Accelerating Drug Discovery for Frontotemporal Degeneration

• Due: May 11, 2026 (LOI)
• Funding: $300,000
• Project Period: 1 year
• Purpose: To support innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy etc.) drug development programs for FTD.
• Eligibility: Open to researchers and clinicians working in academic medical centers, universities or nonprofits; biotechnology companies that demonstrate a clear need for nonprofit funding, existing companies and new spinouts are eligible. Industry partnerships are encouraged.

Neurocritical Care Society (NCS) – NCS Research Training Fellowship

• Due: May 26, 2026
• Funding: Up to $100,000
• Project Period: 1 year
• Purpose: To support individuals with high potential to become independent researchers in the field of neurocritical care in obtaining preliminary data necessary to apply for subsequent scientist development training grants to conduct clinical, translational, and outcomes research aimed at developing innovative and cost-effective interventions for acute neurological disorders.
• Eligibility: Applicants must be active NCS members within 5 years of completion of terminal degree or clinical training (physicians, advanced practitioners, nurses, pharmacists, PhD researchers, etc. at all levels) and be interested in becoming an independent researcher. 75% protected time, a mentor who is an established investigator with independent funding, and the applicant’s institutional/departmental chair’s support are required (including a written commitment to providing supplemental salary and research expenses funding).

PhRMA Foundation – Translational Medicine Faculty Starter Grants

• Due: May 27, 2026 (LOI)
• Funding: $100,000
• Project Period: 1 year
• Purpose: To support U.S.-based education projects to increase the awareness of healthcare professionals (HCPs) on the opportunities and challenges of applying artificial intelligence, integrated diagnostic & antifungal stewardship and clinical decision support tools to improve speed and precision of treatment selection and to enhance clinical management for patients with invasive mold infections (IMIs).
• Eligibility: Applicants must be full-time, promotion-eligible, research-intensive faculty (with faculty status that began after January 1, 2025 and a terminal degree conferred after January 1, 2017) at a PhD-granting accredited U.S. university by the time of LOI submission. Preference will be given to applicants with startup funding less than $750,000. Applicants with funding over $250,000 are ineligible. A minimum of three first author publications is required for eligibility.

June

American Cancer Society – Clinician Scientist Development Grant (CSDG)

• Due: June 1, 2026
• Funding: $135,000 per year
• Project Period: 3 to 5 years
• Purpose: To support full-time faculty (trained primarily as clinicians) seeking to establish themselves as independent clinician-scientists.
• Eligibility: Clinician trained, independent investigators who have a doctoral degree, an active clinical license, and who participate in clinical care may apply. Applicants must work at a U.S. academic institution or eligible non-profit. Applicants must not be a current or former PI of an individual mentored training grant or PI of an independent extramural research grant that is more than 1 year and more than $100,000, including multi-PI awards.

American Cancer Society – Mission Boost Grants (MBG)

• Due: June 1, 2026
• Funding: $66,000, $68,000, and $70,000 a year stipend
• Project Period: Up to 3 years
• Purpose: To support research projects that specifically focus on translation to human testing.
• Eligibility: Independent investigators at any career stage, with a full-time faculty appointment (or equivalent), who work at an academic institution in the U.S. or eligible nonprofit may apply.

American Cancer Society – Postdoctoral Fellowships

• Due: June 1, 2026
• Funding: $66,000, $68,000, and $70,000 a year stipend
• Project Period: Up to 3 years
• Purpose: To support new investigators in research training programs to position them for independent careers in cancer research.
• Eligibility: Applicants must be a U.S. citizen or a non-U.S. citizen with an appropriate visa or lawful immigration status at the time of application, and be in a postdoctoral position at a U.S. academic institution or eligible non-profit. Applicants must have received their terminal degree no more than three years prior to time of application.

American Cancer Society – Research Scholar Grants

• Due: June 1, 2026
• Funding: Up to $215,000 per year
• Project Period: Up to four years
• Purpose: To support investigator-initiated grant proposals that align with an American Cancer Society’s priority research area (Etiology, Obesity/Healthy Eating and Active Living (HEAL), Screening and Diagnosis, Treatment, and Survivorship.
• Eligibility: Applicants must have had their first appointment as an independent, full-time faculty less than 10 years ago and must work at a U.S. academic institution or eligible non-profit. At time of application, applicants can be PI on no more than 1 R01 or R01 equivalent grant (R01 equivalent grant is defined as an award that is more $100, 000 direct costs per year for more than three years).

Incyte – Ingenuity Award in GVHD™

• Due: June 12, 2026 (LOI)
• Funding: $135,000
• Project Period: 1 year
• Purpose: To support the graft-versus-host disease (GVHD) community by funding novel initiatives that address challenges faced by GVHD patients, caregivers, and healthcare providers.
• Eligibility: Invited applicants will be asked to complete a round two application form. U.S.-based non-profit 501(c)(3), patient, policy and caregiver organizations, Healthcare providers, junior faculty from healthcare organizations, individuals or other companies collaborating with these organizations and institutions may apply.

July

American Association of Obstetrics and Gynecologists Foundation – Research and Training Scholarship

• Due: July 1, 2026
• Funding: $150,000 per year
• Project Period: Up to 3 years
• Purpose: A joint effort (ABOG/AAOGF & the Foundation for SMFM/AOGF) to support basic or translational research, disease pathogenesis, clinical diagnostics, interventions and prevention, epidemiology, and health services research by a candidate of proven ability who demonstrates significant talent, novel thought, and evidence of dedication to an academic career in Obstetrics and Gynecology in the U.S. or Canada.
• Eligibility: Eligible applicants must hold an MD or DO, have completed or expect to complete residency training in obstetrics and gynecology in the U.S.or Canada, and be eligible for ABOG certification. Membership in the Society for Maternal-Fetal Medicine (SMFM) and 75% protected time are required. Grant awardees with more than two years of prior K-award training, current recipients of certain K12 awards, or prior/current R01 grant holders are not eligible. Collaborative efforts with other departments strongly encouraged.

Awards

Science & PINS – Science & PINS Prize for Neuromodulation

• Due: March 15, 2026
• Prize: : $25,000 (Winner), $5,000 (Runner-up)
• Purpose: To recognize innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine. The winner’s essay published in Science. The runner-up’s essay is published on Science Online.
• Eligibility: Intended for scientists conducting research at the intersection of engineering and clinical neurology. Applicnts’ research must have been performed during the previous three years and they must have performed or directed the work described in the essay.

Elevance Health Foundation – Patient Safety Prize

• Due: March 17, 2026
• Prize: Up to $1.5 million each for up to 3 Winners; up to $250,000 each for up to two 2 Honorable Mentions.
• Project Period: 1 year
• Purpose: To address large-scale community health needs and incentivize action for change. The inaugural Community Action Leadership challenge focuses on patient safety in three key areas: Empowering Health Literacy for Safer Patient Care, Innovating to Eliminate Medication Errors, and Promoting Fall-Free Futures. 
• Eligibility: Applications from nonprofit and for-profit entities within the U.S. and U.S. territories may apply. Each applicant must identify a Lead Organization who will assume responsibility for the receipt and management of any award received.

Science & SciLifeLab – Patient Safety Prize

• Due: July 15, 2026
• Prize:$30,000 (grand prize winner), $10,000 (for each category winners)
• Project Period: 1 year
• Purpose: To recognize one young scientist for outstanding life science research for which they earned a doctoral degree in the previous two years (the research must have been performed while the entrant was a graduate student). The grand prize-winning essay will be published in Science; essays from the each category winner will be published online.
• Eligibility: Applicants must have been awarded their doctoral degree in 2024 or 2025, and the subject of their thesis should match one of the preferred subject tracks (Cell and Molecular Biology; Genomics, Proteomics and Systems Biology approaches; Ecology and Environment; and Molecular Medicine).